Report cover image

Insulin Delivery Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Publisher GlobalData
Published Jul 26, 2023
Length 246 Pages
SKU # GBDT18140970

Description

Insulin Delivery Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update


Summary

GlobalData's Medical Devices sector report, “Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Insulin Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Insulin delivery devices are used to inject measured doses of insulin through the skin and into the fatty tissues below.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Insulin Delivery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Insulin Delivery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Insulin Delivery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

246 Pages
  • About GlobalData
    • Insulin Delivery Overview
    • Insulin Delivery - Pipeline Products by Stage of Development
    • Insulin Delivery - Pipeline Products by Segment
    • Insulin Delivery - Pipeline Products by Territory
    • Insulin Delivery - Pipeline Products by Regulatory Path
    • Insulin Delivery - Pipeline Products by Estimated Approval Date
    • Insulin Delivery - Ongoing Clinical Trials
    • Insulin Delivery Companies - Pipeline Products by Stage of Development
    • Insulin Delivery - Companies Pipeline Products by Stage of Development
    • Abbott Diabetes Care Inc Company Overview
    • Aerami Therapeutics Inc Company Overview
    • Alshifa Medical Syringes Manufacturing Co Ltd Company Overview
    • American Chemical Society Company Overview
    • AMF Medical SA Company Overview
    • Amrita Vishwa Vidyapeetham Company Overview
    • Andain, Inc Company Overview
    • Animas Corp Company Overview
    • ASTI Corp Company Overview
    • Avecho Biotechnology Ltd Company Overview
    • Bigfoot Biomedical Inc Company Overview
    • Biocon Ltd Company Overview
    • Cambridge Consultants Ltd Company Overview
    • Cellnovo Ltd (Inactive) Company Overview
    • Companion Medical Inc Company Overview
    • ConvaTec Group Plc Company Overview
    • Debiotech SA Company Overview
    • Defymed SAS Company Overview
    • Dermisonics Inc Company Overview
    • Eli Lilly and Co Company Overview
    • Embecta Corp Company Overview
    • Emperra GmbH E-Health Technologies Company Overview
    • EOFlow Co Ltd Company Overview
    • Erech Finance Cahalacha Ltd Company Overview
    • GO-Pen ApS Company Overview
    • Hospira Inc Company Overview
    • Houston Methodist Research Institute Company Overview
    • Imagine Medical Device Inc. Company Overview
    • InsuLenz Company Overview
    • Insulet Corp Company Overview
    • Iowa State University Company Overview
    • Kailian Medical Technology Co Ltd Company Overview
    • LifeScan Inc Company Overview
    • MannKind Corp Company Overview
    • Medical International Technologies (Mit Canada) Inc Company Overview
    • Medicsensors SL Company Overview
    • MedPro Safety Products, Inc. Company Overview
    • MedSolve Technologies, Inc. Company Overview
    • Medtronic MiniMed Inc Company Overview
    • Medtronic Plc Company Overview
    • MicroPort Scientific Corp Company Overview
    • MicroTech Medical Co Ltd Company Overview
    • Modular Medical Inc Company Overview
    • NanoDerma Ltd Company Overview
    • nGageIT Digital Health Inc Company Overview
    • Nitto Denko Corp Company Overview
    • North Carolina State University Company Overview
    • Novo Nordisk AS Company Overview
    • NuGen Medical Devices Inc Company Overview
    • Pennsylvania State University Company Overview
    • Perikinetics Inc Company Overview
    • Phluid Corporation Company Overview
    • PhysioLogic Devices Inc Company Overview
    • PositiveID Corp Company Overview
    • Prometheon Pharma LLC Company Overview
    • Qlibrium Inc Company Overview
    • Sanofi Company Overview
    • SFC Fluidics LLC Company Overview
    • Sooil Development Co., Ltd. Company Overview
    • Spring Health Solutions Ltd. Company Overview
    • Tandem Diabetes Care Inc Company Overview
    • TempraMed Israel Ltd Company Overview
    • Thermalin Inc Company Overview
    • Transdermal Specialties Inc Company Overview
    • Triple Jump Israel Ltd Company Overview
    • University of KwaZulu-Natal Company Overview
    • University of Limerick Company Overview
    • University of Massachusetts Amherst Company Overview
    • University of Missouri-Kansas City Company Overview
    • University of North Carolina Company Overview
    • University of Toronto Company Overview
    • Univlabs Technologies Pvt Ltd Company Overview
    • Unomedical a/s Company Overview
    • Valeritas Inc Company Overview
    • ViCentra BV Company Overview
    • Vigmed Holding AB Company Overview
    • Washington University School of Medicine Company Overview
    • Ypsomed Holding AG Company Overview
    • Zealand Pharma AS Company Overview
    • Zenomics Inc Company Overview
    • Jul 11, 2023: Microport Scientific Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023
    • Jul 05, 2023: Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023
    • Jun 29, 2023: Dr. Milos R. Popovic appointed Director of the Institute of Biomedical Engineering at UofT
    • Jun 12, 2023: Medtronic to present new data on its intelligent dosing platforms at the American Diabetes Association 83rd Scientific Sessions
    • May 24, 2023: Dr. Burkhard Blank joins MannKind as executive vice president of research & development and chief medical officer
    • May 12, 2023: Embecta reports second quarter fiscal 2023 financial results
    • May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
    • May 09, 2023: Mannkind reports 2023 first quarter financial results
    • May 02, 2023: MannKind Corp. to hold 2023 first quarter financial results conference call on May 9, 2023
    • Apr 27, 2023: Integer Holdings reports First Quarter 2023 results
    • Apr 26, 2023: Nitto Denko announces supplementary data of consolidated financial statements for the year ended March 31, 2023
    • Apr 26, 2023: Nitto Denko announces summary of consolidated financial statements of fiscal 2022
    • Apr 26, 2023: MicroPort announces annual results for 2022
    • Apr 20, 2023: embecta to report fiscal second quarter 2023 financial Results
    • Apr 18, 2023: Johnson & Johnson Reports Q1 2023 Results
    • Apr 13, 2023: Lilly Confirms Date and Conference Call for First-Quarter 2023 Financial Results
    • Apr 12, 2023: Medtronic has a layoff in California
    • Apr 11, 2023: J&J talc unit 2nd bankruptcy must be dismissed
    • Apr 10, 2023: Henry Ford Health Appoints New Orthopedics Chair and Medical Director
    • Mar 30, 2023: Integer Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023
    • Mar 27, 2023: Lauren Sabella Joins Mannkind as Executive Vice President, Chief Operating Officer
    • Mar 22, 2023: ConvaTec Group Notice of Annual General Meeting
    • Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
    • Mar 15, 2023: Novo Nordisk to reduce US list prices of insulin products
    • Mar 09, 2023: ConvaTec Group Announces Annual Results for the twelve months ended 31 December 2022
    • Feb 24, 2023: Insulet Reports Full Year 2022 Revenue Increase of 19% and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year
    • Feb 23, 2023: MannKind Corp. Reports 2022 Fourth Quarter and Full Year Financial Results
    • Feb 22, 2023: Novo Nordisk Notice for the Annual General Meeting
    • Feb 22, 2023: embecta sponsors educational symposium at ATTD 2023
    • Feb 16, 2023: Integer Holdings Reports Results for Fourth Quarter and Full Year 2022
    • Feb 16, 2023: MannKind Corp. to Hold 2022 Fourth Quarter and Full Year Financial Results Conference Call on February 23, 2023
    • Feb 14, 2023: Embecta Reports First Quarter Fiscal 2023 Financial Results
    • Feb 09, 2023: AstraZeneca Announces Final Results
    • Feb 09, 2023: Pfizer Announces Appointment of Meenakshi Nevatia as the Managing Director
    • Feb 02, 2023: F. Hoffmann-La Roche Announces Financial Results for fiscal 2022
    • Jan 31, 2023: Civica welcomes Ypsomed as Injection Pen partner for its affordable insulin initiative
    • Jan 26, 2023: Nitto Denko Announces Summary of Consolidated Financial Statements for the Third Quarter Ended December 31, 2022
    • Jan 24, 2023: embecta to Report Fiscal First Quarter 2023 Financial Results
    • Jan 19, 2023: Lilly Confirms Date and Conference Call for Fourth-Quarter 2022 Financial Results
    • Jan 19, 2023: Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
    • Jan 12, 2023: Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
    • Jan 06, 2023: BD Announces Webcast of Annual Meeting of Shareholders
    • Dec 30, 2022: AstraZeneca : Director/PDMR Shareholding
    • Dec 20, 2022: Embecta Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
    • Dec 13, 2022: Thomas Schinecker replaces Severin Schwan as Roche's new CEO
    • Dec 13, 2022: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
    • Dec 08, 2022: BD Releases 2022 Global Inclusion, Diversity and Equity Annual Report
    • Dec 07, 2022: Johnson & Johnson to Participate in the 41st Annual J.P. Morgan Healthcare Conference
    • Nov 29, 2022: Lilly Confirms Date and Conference Call for 2023 Financial Guidance Announcement
    • Nov 23, 2022: Medtronic Reports Quarterly Earnings
    • Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
    • Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
    • Nov 15, 2022: Biocon Q2 revenue up 23% at Rs 2,384 crore, net profit dips at 66% to Rs 47 crore owing to exceptional items
    • Nov 14, 2022: EOFlow Reports Third Quarter 2022 Revenue of 3.5 Billion KRW...Increase of 916% Year-Over-Year
    • Nov 14, 2022: Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&D Spend at Rs 252 Crore, Up 52%
    • Nov 08, 2022: MannKind Reports 2022 Third Quarter Financial Results
    • Nov 04, 2022: Poly Medicure Announces Unaudited Standalone & Consolidated Financial Results for the Quarter Ended 0n 30th Sep. 2022
    • Nov 03, 2022: embecta to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results
    • Nov 01, 2022: Lilly Reports Solid Third-Quarter 2022 Financial Results and Continued Pipeline Progress
    • Oct 27, 2022: Integer Holdings Reports Third Quarter 2022 Results
    • Oct 26, 2022: Nitto Denko Announces Supplementary Data of Consolidated Financial Statements for the Second Quarter Ended September 30, 2022
    • Oct 26, 2022: Nitto Denko announces Financial Results Second Quarter FY2022
    • Oct 19, 2022: Lilly Confirms Date and Conference Call for Third-Quarter 2022 Financial Results Announcement
    • Oct 18, 2022: Johnson & Johnson Reports Q3 2022 Results
    • Oct 06, 2022: Pfizer appoints Deb Mangone as Ireland country manager
    • Sep 30, 2022: AstraZeneca announces Remuneration committee chair appointment
    • Sep 22, 2022: Insulet to Announce Third Quarter 2022 Financial Results on November 3, 2022
    • Sep 22, 2022: MicroTech Medical Inc announced interim report for 2022
    • Sep 21, 2022: MannKind to Participate in the Lytham Partners Fall 2022 Investor Conference
    • Sep 20, 2022: Pfizer Invites Public to View and Listen to Webcast of November 1 Conference Call with Analysts
    • Sep 13, 2022: Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
    • Sep 08, 2022: Robert G. Riney Named Henry Ford Health President and CEO
    • Sep 07, 2022: Medtronic to appear at September investor conferences
    • Sep 06, 2022: LifeScan Names Rekha Ramesh Chief Digital and Information Officer
    • Sep 06, 2022: Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
    • Sep 05, 2022: Sanofi announce Evolution of the Board of Directors
    • Sep 01, 2022: Bayer Announces Appointment of Kimberly Mathisen to Supervisory Board
    • Aug 31, 2022: Lilly to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
    • Aug 31, 2022: Pfizer lures first chief marketing officer from Verily
    • Aug 25, 2022: Lilly to Participate in Citi's 17th Annual BioPharma Conference
    • Aug 24, 2022: Johnson & Johnson Appoints Larry Merlo as Non-Executive Chair Designate of Planned New Consumer Health Company
    • Aug 24, 2022: BD to Present at the Wells Fargo 2022 Healthcare Conference
    • Aug 24, 2022: JNJ Appoints Merlo as Non-Executive Chair Designate
    • Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
    • Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
    • Aug 22, 2022: Tandem Diabetes Care Announces Upcoming Conference Presentations
    • Aug 20, 2022: Herbert Smith Freehills advises Sanofi on €300 million equity investment in Innovent
    • Aug 19, 2022: Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
    • Aug 18, 2022: embecta to Participate in Upcoming Investor Conferences in September
    • Aug 17, 2022: Cambridge Cognition selected by the University of Oxford as a cognitive assessment partner for the ISAP study
    • Aug 15, 2022: Retractable Technologies Announces Results for the Periods Ended June 30, 2022
    • Aug 09, 2022: Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
    • Aug 04, 2022: Poly Medicure announces Financial results For The Quarter Ended 30Th June 2022
    • Aug 02, 2022: Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference
    • Aug 01, 2022: Audrey Derveloy appointed President of Sanofi France
    • Jul 29, 2022: AstraZeneca announce Michel Demaré to succeed Leif Johansson as Non-Executive Chair of the Board
    • Jul 28, 2022: Sanofi's half-year financial report for 2022
    • Jul 28, 2022: Integer Holdings Reports Second Quarter 2022 Results
    • Jul 27, 2022: Biocon announces Financial Results For The Quarter Ended June 30, 2022
    • Jul 26, 2022: Hospital leaders explore the future of insulin management at Glytec's Conference on Glycemic Innovation and Collaboration
    • Jul 26, 2022: Nitto Denko Consolidated Financial Statements for the First Quarter Ended June 30, 2022
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.